Gemtuzumab ozogamicin versus best supportive care in older patients with newly diagnosed acute myeloid leukemia unsuitable for intensive chemotherapy: results of the randomized phase III EORTC-GIMEMA AML-19 trial - Amadori, S; Suciu, S; Selleslag, D (J Clin Oncol, 2016)
, et al.